Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
ISRG
|
Robert De Santis
EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct | 396 Added 6.49% |
$117,417
$296.51 p/Share
|
Aug 26
2024 |
KRBP
|
Pietro Bersani
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 988 Added 0.69% |
$1,906
$1.93 p/Share
|
Aug 26
2024 |
KYMR
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct | 5,000 Added 50.0% |
$51,700
$10.34 p/Share
|
Aug 26
2024 |
KYMR
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 100.0% |
$245,500
$49.1 p/Share
|
Aug 26
2024 |
BHF
|
Eric T Steigerwalt
President and CEO |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 7.22% |
$1,141,750
$45.67 p/Share
|
Aug 26
2024 |
UNOV
|
Giorgio R. Saumat
CEO |
BUY
Open market or private purchase
|
Direct | 104,732 Added 0.09% |
$20,946
$0.2 p/Share
|
Aug 26
2024 |
NRIX
|
Christine Ring
Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 9,870 Added 22.26% |
$56,456
$5.72 p/Share
|
Aug 26
2024 |
NRIX
|
Christine Ring
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 9,870 Reduced 28.64% |
$246,848
$25.01 p/Share
|
Aug 26
2024 |
NMRA
|
Joshua Pinto
Chief Financial Officer |
SELL
Open market or private sale
|
Indirect | 31,642 Reduced 0.0% |
$372,742
$11.78 p/Share
|
Aug 26
2024 |
ROAD
|
Mark R Matteson |
SELL
Bona fide gift
|
Indirect | 8,000 Reduced 0.0% |
-
|
Aug 26
2024 |
BSM
|
Carrie Pearson Clark
SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 18,532 Reduced 13.68% |
$275,014
$14.84 p/Share
|
Aug 26
2024 |
AUID
|
Thomas Robert Szoke
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 14.86% |
$41,500
$8.3 p/Share
|
Aug 26
2024 |
AGRX
|
Geoffrey Gilmore
Chief Administrative Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 20,256 Reduced 100.0% |
$30,789
$1.52 p/Share
|
Aug 26
2024 |
SSB
|
Stephen Dean Young
Chief Strategy Officer |
SELL
Bona fide gift
|
Direct | 2,500 Reduced 6.73% |
-
|
Aug 26
2024 |
AGRX
|
Amy Welsh
Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 13,500 Reduced 100.0% |
$20,520
$1.52 p/Share
|
Aug 26
2024 |
AGRX
|
Paul Korner
Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 13,500 Reduced 100.0% |
$20,520
$1.52 p/Share
|
Aug 26
2024 |
AGRX
|
Robert G Conway
Chief Supply Chain Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 13,529 Reduced 100.0% |
$20,564
$1.52 p/Share
|
Aug 26
2024 |
NRIX
|
Hans Van Houte
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 39.21% |
$504,400
$25.22 p/Share
|
Aug 26
2024 |
AGRX
|
Scott M Coiante
Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 20,080 Reduced 100.0% |
$30,521
$1.52 p/Share
|
Aug 26
2024 |
AGRX
|
Sharon Barbari
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 973 Reduced 100.0% |
$1,478
$1.52 p/Share
|
Aug 26
2024 |
AGRX
|
Josephine Torrente
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 987 Reduced 100.0% |
$1,500
$1.52 p/Share
|
Aug 26
2024 |
AGRX
|
John W Hubbard
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 976 Reduced 100.0% |
$1,483
$1.52 p/Share
|
Aug 26
2024 |
AGRX
|
Seth H. Z. Fischer
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 976 Reduced 100.0% |
$1,483
$1.52 p/Share
|
Aug 26
2024 |
AGRX
|
Alfred Altomari
Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 47,749 Reduced 100.0% |
$72,578
$1.52 p/Share
|
Aug 26
2024 |
AGRX
|
Sandra Carson
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 973 Reduced 100.0% |
$1,478
$1.52 p/Share
|
Aug 26
2024 |
SCKT
|
William L. Parnell Jr
Director |
BUY
Open market or private purchase
|
Direct | 10,000 Added 23.81% |
$11,000
$1.1 p/Share
|
Aug 26
2024 |
SCKT
|
Charlie Bass
Director |
BUY
Open market or private purchase
|
Direct | 10,000 Added 0.69% |
$11,000
$1.1 p/Share
|
Aug 26
2024 |
SSB
|
John C Corbett
CEO |
SELL
Bona fide gift
|
Direct | 3,500 Reduced 3.97% |
-
|
Aug 26
2024 |
HGTY
|
Robert I Kauffman
Director |
SELL
Open market or private sale
|
Indirect | 6,318 Reduced 0.0% |
$74,868
$11.85 p/Share
|
Aug 26
2024 |
PRI
|
Peter W. Schneider
President |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 12.76% |
$391,665
$261.11 p/Share
|
Aug 26
2024 |
SMHI
|
Andrew R Morse |
SELL
Bona fide gift
|
Direct | 2,700 Reduced 1.88% |
-
|
Aug 26
2024 |
PKOH
|
Edward F Crawford
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 99,075 Added 0.0% |
$2,999,991
$30.28 p/Share
|
Aug 26
2024 |
RXRX
|
Christopher Gibson
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 5,000 Added 0.67% |
$12,400
$2.48 p/Share
|
Aug 26
2024 |
CMS
|
Brandon J. Hofmeister
Senior Vice President |
SELL
Bona fide gift
|
Direct | 1 Reduced 0.0% |
-
|
Aug 26
2024 |
CMS
|
Brandon J. Hofmeister
Senior Vice President |
BUY
Bona fide gift
|
Indirect | 1 Added 0.0% |
-
|
Aug 26
2024 |
PKOH
|
Matthew V Crawford
CEO, COB, President |
BUY
Grant, award, or other acquisition
|
Indirect | 99,075 Added 0.0% |
$2,999,991
$30.28 p/Share
|
Aug 26
2024 |
PKOH
|
Matthew V Crawford
CEO, COB, President |
BUY
Grant, award, or other acquisition
|
Direct | 49,537 Added 4.81% |
$1,499,980
$30.28 p/Share
|
Aug 26
2024 |
UTHR
|
James Edgemond
CFO AND TREASURER |
SELL
Open market or private sale
|
Direct | 7,799 Reduced 74.89% |
$2,710,932
$347.6 p/Share
|
Aug 26
2024 |
UTHR
|
James Edgemond
CFO AND TREASURER |
BUY
Exercise of conversion of derivative security
|
Direct | 8,332 Added 72.31% |
$991,591
$119.01 p/Share
|
Aug 26
2024 |
BSX
|
Arthur C Butcher
EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct | 14,012 Reduced 56.47% |
$1,110,451
$79.25 p/Share
|
Aug 26
2024 |
BSX
|
Arthur C Butcher
EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct | 4,185 Added 14.43% |
$83,658
$19.99 p/Share
|
Aug 26
2024 |
DUOL
|
Severin Hacker
Chief Tech Officer, Co-Founder |
SELL
Bona fide gift
|
Indirect | 15,000 Reduced 0.0% |
-
|
Aug 26
2024 |
LLY
|
Donald A Zakrowski
SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct | 750 Reduced 10.52% |
$712,500
$950.0 p/Share
|
Aug 26
2024 |
RNG
|
Robert I Theis |
SELL
Open market or private sale
|
Direct | 8,448 Reduced 21.09% |
$287,232
$34.0 p/Share
|
Aug 26
2024 |
MRDB
|
Meridian Bid Co LLC |
BUY
Open market or private purchase
|
Direct | 7,803,747 Added 10.15% |
$4,292,060
$0.55 p/Share
|
Aug 26
2024 |
IDN
|
Jeffrey Ishmael
CFO, COO |
SELL
Open market or private sale
|
Direct | 4,179 Reduced 1.85% |
$9,444
$2.26 p/Share
|
Aug 26
2024 |
CVUA
|
Richard S Caswell
Director |
BUY
Open market or private purchase
|
Direct | 10,000 Added 6.99% |
$28,800
$2.88 p/Share
|
Aug 26
2024 |
CYTK
|
B Lynne Parshall
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 19.53% |
$286,300
$57.26 p/Share
|
Aug 26
2024 |
CYTK
|
B Lynne Parshall
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 5,000 Added 16.34% |
$108,050
$21.61 p/Share
|
Aug 26
2024 |
FELE
|
Jonathan M. Grandon
Chief Administrative Officer |
SELL
Open market or private sale
|
Direct | 2,219 Reduced 12.26% |
$228,601
$103.02 p/Share
|
Aug 26
2024 |